News
Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
Not only is there a significant good clinical practice (GCP) expectation, Risk-Based Monitoring (RBM)...
Read
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data...
Read
Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information...
Read
We’re delighted to announce that registration for CluePoints’ US Risk-Based Quality Management Roadshow is...
Read
Since the introduction of the ICH E6 (R2) addendum, the industry has seen a rise in the implementation...
Read
The ICH E6 R2 Addendum is starting to have a significant, positive impact on clinical trial design –...
Read
